JPS58172388A - Novel vitamin d3 derivative - Google Patents
Novel vitamin d3 derivativeInfo
- Publication number
- JPS58172388A JPS58172388A JP5368682A JP5368682A JPS58172388A JP S58172388 A JPS58172388 A JP S58172388A JP 5368682 A JP5368682 A JP 5368682A JP 5368682 A JP5368682 A JP 5368682A JP S58172388 A JPS58172388 A JP S58172388A
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- compound
- sulfur dioxide
- formula
- reacting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は一般式(’I)で示されるビタミンI)34導
体に閃する。DETAILED DESCRIPTION OF THE INVENTION The present invention is directed to a vitamin I) 34 conductor represented by the general formula ('I).
(式中R1は芳香族又は低級脂肪族のアシル基を意味し
、R2、R3は同−又は異なって水素原子、水酸基又は
保護された水酸基を意味する。)一般式(1)で示され
る本発明の化合物は、血中のビタミンD3類、例えば2
5−ヒドロ牛シビタミ7 D3、la、25−ジヒドロ
キシビタミンD3等を抗原抗体反応を用いて測定する際
に必要な抗体を製造するための一般式(IJ)で示され
るハプテ/の合成中間体として又はその他種々のビタミ
ンD3誘導体を製造するための中間体として極めて有用
である。(In the formula, R1 means an aromatic or lower aliphatic acyl group, and R2 and R3 are the same or different and mean a hydrogen atom, a hydroxyl group, or a protected hydroxyl group.) The compounds of the invention improve blood vitamin D3, e.g.
As a synthetic intermediate for hapte/ represented by the general formula (IJ) for producing antibodies necessary when measuring 5-hydrobixvitami7 D3, la, 25-dihydroxyvitamin D3, etc. using an antigen-antibody reaction. It is also extremely useful as an intermediate for producing various other vitamin D3 derivatives.
(式中R’2S R’lは同−又は異なって水素原子又
は水酸基を意味し、nは2乃至4の整数を意味する。)
従来知られているビタミンD3類の二酸化イオウの付加
体としては、その3位が水酸基かまたはテトラヒドロピ
ラニル基等のエーテル系の保護基で保護された水酸基の
ものがある。しかしながらこれらの化合物は酸に対して
極めて不安定であり酸化剤を用いた合成反応には使用し
得ない。(In the formula, R'2S R'l are the same or different and mean a hydrogen atom or a hydroxyl group, and n means an integer of 2 to 4.) As a conventionally known adduct of vitamin D3 with sulfur dioxide. has a hydroxyl group at the 3-position or a hydroxyl group protected with an ether-based protecting group such as a tetrahydropyranyl group. However, these compounds are extremely unstable to acids and cannot be used in synthetic reactions using oxidizing agents.
本発明者はこれらの事情に鑑み税金研究した結果、本発
明の3位が芳香族又□は脂肪族のアシル基で保護された
化合物は酸に対して極めて安定で酸を用いた種々の合成
反応、例えば酸性条(’l下における6位又は19位の
アルキル化反応等の原料として有用であることを見い出
した。更に驚くべきことに本発明の化合物はそれ自体極
めて安定であり長期の保存に耐えるなどの合成原料とし
ては最適の物性をaしている。In view of these circumstances, the inventor conducted research and found that the compound of the present invention in which the 3-position is protected by an aromatic or aliphatic acyl group is extremely stable against acids, and is suitable for various syntheses using acids. It has been found that the compounds of the present invention are useful as raw materials for reactions such as alkylation reactions at the 6- or 19-position under acidic conditions.Furthermore, surprisingly, the compounds of the present invention are themselves extremely stable and can be stored for long periods of time. It has optimal physical properties as a synthetic raw material, such as being resistant to
本発明の化合物は新規化合物であり、例えば対応するビ
タミンD3類、具体的にはビタミンD3.25−ヒドロ
キシビタミ/D3.24.25−ジヒドロキシビタミン
D3に二酸化イオウを反応せしめ得られる一般式(Il
l)で示される化合物を常法により、例えば酸ハライド
又は酸無水物と有機塩基との反応に付し製造するか又は
前記のビタミンD3類の3位を先にアシル化し、次いで
二酸化イオウを反応せしめることにより製造される。The compound of the present invention is a new compound, for example, the general formula (Il
The compound represented by l) is produced by a conventional method, for example, by reacting an acid halide or acid anhydride with an organic base, or by first acylating the 3-position of the vitamin D3, and then reacting with sulfur dioxide. Manufactured by forcing.
ρつ
(式中R2、R3は航紀と同じものを意味する。)本発
明の化合物においてアシル基としては、芳香族アシル基
又は低級脂肪族アシル基である。芳香族アシル基として
は例えばベンゾイル基、p−二トロベンゾイル基、ナフ
トイル基等であり、低級脂肪族アシル基としては例えば
アセチル基、プロパノイル基、ブチリル基等である。又
17位の側鎖の水酸基の保護基としては特に制限はない
が、好ましくは芳香族又は低級脂肪族のアシル基である
。(In the formula, R2 and R3 have the same meanings as in Koki.) The acyl group in the compound of the present invention is an aromatic acyl group or a lower aliphatic acyl group. Examples of the aromatic acyl group include a benzoyl group, p-nitrobenzoyl group, and naphthoyl group, and examples of the lower aliphatic acyl group include an acetyl group, a propanoyl group, and a butyryl group. There are no particular restrictions on the protecting group for the hydroxyl group in the side chain at position 17, but aromatic or lower aliphatic acyl groups are preferred.
実施例1
ビタミンD32.1gを10m1のピリジンに溶解し、
無水酢酸10m1を加える。室潟で約2時間撹拌し氷水
中に注ぐ。酢酸エチルで抽出し希塩酸、水の順に洗浄し
、硫酸マグネンウムで乾燥する。酢酸エチルを留去する
とビタミンD3アセテートの油状残渣2.3gを得る。Example 1 32.1 g of vitamin D was dissolved in 10 ml of pyridine,
Add 10 ml of acetic anhydride. Stir in Murogata for about 2 hours and pour into ice water. Extract with ethyl acetate, wash sequentially with dilute hydrochloric acid and water, and dry with magnesium sulfate. Distilling off the ethyl acetate yields 2.3 g of an oily residue of vitamin D3 acetate.
残渣をジク【1ルメタ73m1に溶解し、トライアイス
で冷却したコールドフィンガーを反応容器に結合する。The residue was dissolved in 73 ml of diluted water and a cold finger cooled with Tri-ice was attached to the reaction vessel.
反応容器内を乾燥アルゴンで置換した後二酸化イオウガ
スを反応液か約3’ Om +になるまで4人する。3
0分から1時間そのままの杖萌で還流する。コールドフ
ィンガーを除去し、過剰の二酸化イオウを減圧留去する
。たたちにンリヵゲルを用いたカラムクロマトグラフィ
ーに付し、ヘキサ/−酢酸エチル(2:1)で溶出する
。目的物を含む7ラクシ:I/を集め溶媒を留去すると
油VのビタミンD3アセテート二酸化イオウ付加物2.
24gを得る。After purging the inside of the reaction vessel with dry argon, sulfur dioxide gas was added to the reaction solution until it reached approximately 3' Om +. 3
Reflux with cane moe for 0 minutes to 1 hour. The cold finger is removed and excess sulfur dioxide is removed under reduced pressure. The product was then subjected to column chromatography using linica gel and eluted with hexa/ethyl acetate (2:1). Collecting the 7 Raksi:I/ containing the target product and distilling off the solvent, the vitamin D3 acetate sulfur dioxide adduct of oil V2.
Obtain 24g.
本物質は6位異性の6g体および6H体(1:1)の混
合物である。This substance is a mixture of 6g isomer and 6H isomer (1:1).
6H異性体 融点123〜125℃(分解)(ジクロ
ルメタン−イソプロ
ピルエーテルより再結晶)
N M Rδ : 5.22〜4.87 (IH,m)
、 4.69 (2H,m) 、 3.69 (2H,
m) 、 2.05(311,s)、0.55 (3H
,5)6S異性体 油伏
NMRδ : 5.22〜4.90 (ill、 m)
、 4.04 (2H,m)、 3. E35 (2t
l、 m)、 2.03(31j s)、 0.64
(3H,s>実施例2
ビタミンD3と二酸化イオウから常法により製したビタ
ミンD3ン二酸化イオウ付加体3.6gをピリジン20
m1に溶解し、無水酢酸20m1を加える。室温下1〜
2時間撹拌した後氷水中に注ぐ。クロロホルムで抽出し
、クロロホルム層を希塩酸、水の順に洗浄し、硫酸マグ
ネシウムで乾燥する。6H isomer Melting point: 123-125°C (decomposed) (recrystallized from dichloromethane-isopropyl ether) NMRδ: 5.22-4.87 (IH, m)
, 4.69 (2H, m) , 3.69 (2H,
m), 2.05 (311,s), 0.55 (3H
,5) 6S isomer NMRδ: 5.22-4.90 (ill, m)
, 4.04 (2H, m), 3. E35 (2t
l, m), 2.03 (31j s), 0.64
(3H,s>Example 2 3.6g of a vitamin D3-sulfur dioxide adduct prepared from vitamin D3 and sulfur dioxide by a conventional method was added to 20% of pyridine.
ml and add 20 ml of acetic anhydride. At room temperature 1~
After stirring for 2 hours, pour into ice water. Extract with chloroform, wash the chloroform layer sequentially with dilute hydrochloric acid and water, and dry with magnesium sulfate.
クロロホルムを留去するとビタミンD3アセテート二酸
化イオウ付加物3.8gを得る。When chloroform is distilled off, 3.8 g of vitamin D3 acetate sulfur dioxide adduct is obtained.
手続補正書(方式) %式% 1、事件の表示 昭和57年特許願第53686号 2、発明の名称 新規なビタミンD3誘導体 3、補正をする者 事件との関係 特許出願人 東京都北区浮間五丁目5番1号 (331) 中外製薬株式会社 代表者 上 野 公 夫 東京都豐鳥区高田三丁目41番8号 中外製薬株式会社内 6、補正の対象 明 細 書 7、補正の内容 別紙のとおり 明細書の浄書 (内容に変更なし) 669Procedural amendment (formality) %formula% 1.Display of the incident 1981 Patent Application No. 53686 2. Name of the invention Novel vitamin D3 derivative 3. Person who makes corrections Relationship to the case Patent applicant 5-5-1 Ukima, Kita-ku, Tokyo (331) Chugai Pharmaceutical Co., Ltd. Representative Kimio Ueno 3-41-8 Takada, Todori-ku, Tokyo Inside Chugai Pharmaceutical Co., Ltd. 6. Subject of correction Specification 7. Contents of correction As per attached sheet Engraving of the detailed statement (no changes to the contents) 669
Claims (1)
、R2、R3は同−又は異なって水素原子、水酸基又は
保護された水酸基を意味する。)で示される化合物。[Claims] In the general formula (wherein R1 means an aromatic or lower aliphatic acyl group, R2 and R3 are the same or different and mean a hydrogen atom, a hydroxyl group or a protected hydroxyl group) Compounds shown.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5368682A JPS58172388A (en) | 1982-04-02 | 1982-04-02 | Novel vitamin d3 derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5368682A JPS58172388A (en) | 1982-04-02 | 1982-04-02 | Novel vitamin d3 derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58172388A true JPS58172388A (en) | 1983-10-11 |
JPH0244312B2 JPH0244312B2 (en) | 1990-10-03 |
Family
ID=12949695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5368682A Granted JPS58172388A (en) | 1982-04-02 | 1982-04-02 | Novel vitamin d3 derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58172388A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107325173A (en) * | 2016-04-28 | 2017-11-07 | 上海惠斯生物科技有限公司 | A kind of artificial antigen of 25(OH)VD 3, preparation method and application |
-
1982
- 1982-04-02 JP JP5368682A patent/JPS58172388A/en active Granted
Non-Patent Citations (1)
Title |
---|
CHEMISTRY LETTERS=1979 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107325173A (en) * | 2016-04-28 | 2017-11-07 | 上海惠斯生物科技有限公司 | A kind of artificial antigen of 25(OH)VD 3, preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
JPH0244312B2 (en) | 1990-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH1192423A (en) | Production of methyl ester or ethyl ester of trifluoroacetic acid and chlorodifluoroacetic acid | |
US5391769A (en) | Method of preparing 3-DPA-lactone | |
GB2053924A (en) | Immunosuppressive 3-hemiesters of7-oxygenated cholesterol | |
EP0168119A1 (en) | Chemiluminescent substituted epidoxy-polycycloalkyl polycycloalkanes and process for preparing these compounds | |
JPS58172388A (en) | Novel vitamin d3 derivative | |
JPS6215057B2 (en) | ||
US4656309A (en) | Preparation of alpha-pivaloyl-substituted acetic acid esters | |
US4008270A (en) | Process for preparing 2-(substituted phenyl)propionic acids | |
Nelson et al. | Steroidal Hormone Analogs. V. The Reaction of Cholestane-3-one with Diazomethane1 | |
JP2652557B2 (en) | Organic germanium compound and method for producing the same | |
JPS597712B2 (en) | Method for producing γ-lactone derivative | |
JPS59110644A (en) | Manufacture of cyclopentenone and novel acetylene ester | |
US3147282A (en) | Preparation of griseofulvin and analogues thereof | |
JPH07206789A (en) | Production of combretastatin analog compound | |
JPS59216841A (en) | Agent for optical resolution | |
JP2662607B2 (en) | Bicyclo [8.3.0] trideca-9,13-diene-2,7-diyne derivative | |
JP2920212B1 (en) | Method for producing 1,3-dioxolan-4-one compound | |
JP2832480B2 (en) | 1,3-pentadiene derivative and method for producing the same | |
JP2540068B2 (en) | Process for producing optically active 1-halogeno-2-alkanols | |
JPS6126555B2 (en) | ||
US3676503A (en) | Process for preparing hydroquinones | |
US4451658A (en) | Process for producing substituted pyrroles | |
JPH0247994B2 (en) | NNARUKIRU22CHENIRUKETONNOSEIZOHO | |
JPS6219598A (en) | 2,3,2'3'-tetra-o-alkyl-alpha,alpha-trehalose derivative | |
JPS58157798A (en) | Preparation of optically active allethrolone |